• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.

作者信息

Lepore L, Marchetti F, Facchini S, Leone V, Ventura A

出版信息

Clin Exp Rheumatol. 2003 Mar-Apr;21(2):276-7.

PMID:12747299
Abstract
摘要

相似文献

1
Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.一名幼年特发性关节炎患儿使用依那西普治疗后发生药物性系统性红斑狼疮。
Clin Exp Rheumatol. 2003 Mar-Apr;21(2):276-7.
2
Etanercept-associated SLE with lupus nephritis.与依那西普相关的系统性红斑狼疮伴狼疮性肾炎。
Lupus. 2009 Jun;18(7):667-8. doi: 10.1177/0961203308100560.
3
Crohn's disease in a patient with juvenile idiopathic arthritis after starting etanercept therapy - causal link or only temporal coincidence?一名青少年特发性关节炎患者在开始使用依那西普治疗后出现克罗恩病——因果关系还是仅仅是时间上的巧合？
Klin Padiatr. 2013 Nov;225(6):350-1. doi: 10.1055/s-0033-1355391. Epub 2013 Oct 28.
4
Granulomatous disease in a child treated with etanercept.一名接受依那西普治疗的儿童的肉芽肿病。
Int J Rheum Dis. 2013 Aug;16(4):472-4. doi: 10.1111/1756-185X.12078.
5
Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.
Rheumatology (Oxford). 2002 Feb;41(2):228-9. doi: 10.1093/rheumatology/41.2.228.
6
TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.肿瘤坏死因子-α拮抗剂诱导的狼疮样综合征：报告及文献复习，并探讨了使用替代肿瘤坏死因子-α拮抗剂治疗的影响。
Int J Dermatol. 2011 May;50(5):619-25. doi: 10.1111/j.1365-4632.2011.04871.x.
7
Drug-induced systemic lupus erythematosus and TNF-alpha blockers.
Lancet. 2002 Aug 24;360(9333):645; author reply 646. doi: 10.1016/s0140-6736(02)09798-2.
8
Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
J Rheumatol. 2007 Dec;34(12):2503-4.
9
[Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with Etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee].儿童与青少年风湿病研究委员会关于依那西普（p75肿瘤坏死因子-α受体免疫球蛋白融合蛋白）治疗的建议。[药物治疗委员会]
Z Rheumatol. 2000 Dec;59(6):365-9. doi: 10.1007/s003930070043.
10
Etanercept improves active polyarticular juvenile rheumatoid arthritis.
Clin Exp Rheumatol. 2001 Mar-Apr;19(2):122-4.

引用本文的文献

1
The signaling pathways and therapeutic potential of itaconate to alleviate inflammation and oxidative stress in inflammatory diseases.异丁酸盐缓解炎症性疾病中炎症和氧化应激的信号通路和治疗潜力。
Redox Biol. 2022 Dec;58:102553. doi: 10.1016/j.redox.2022.102553. Epub 2022 Nov 23.
2
Noncompetitive Allosteric Antagonism of Death Receptor 5 by a Synthetic Affibody Ligand.死亡受体 5 的合成亲和体配体的非竞争性变构拮抗作用。
Biochemistry. 2020 Oct 13;59(40):3856-3868. doi: 10.1021/acs.biochem.0c00529. Epub 2020 Sep 30.
3
Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting.
在实际临床环境中，与抗肿瘤坏死因子α制剂相关的严重不良事件在儿童期起病的炎症性肠病和幼年特发性关节炎中的情况
Paediatr Drugs. 2018 Apr;20(2):165-171. doi: 10.1007/s40272-017-0267-8.
4
The development and assessment of biological treatments for children.儿童生物治疗的开发与评估。
Br J Clin Pharmacol. 2015 Mar;79(3):379-94. doi: 10.1111/bcp.12406.
5
Clinical utility of etanercept in the treatment of arthritides in children and adolescents.依那西普在儿童和青少年关节炎治疗中的临床应用
Adolesc Health Med Ther. 2014 Mar 26;5:35-48. doi: 10.2147/AHMT.S38909. eCollection 2014.
6
Heat shock protein bystander antigens for peptide immunotherapy in autoimmune disease.热休克蛋白旁观者抗原在自身免疫性疾病中的肽免疫治疗。
Clin Exp Immunol. 2013 Jan;171(1):20-9. doi: 10.1111/j.1365-2249.2012.04627.x.
7
Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelines.监测肺疾病和肺移植受者的非甾体免疫抑制剂：美国胸科医师学会循证临床实践指南。
Chest. 2012 Nov;142(5):e1S-e111S. doi: 10.1378/chest.12-1044.
8
The safety profile of biologic therapies for juvenile idiopathic arthritis.生物制剂治疗幼年特发性关节炎的安全性特征。
Nat Rev Rheumatol. 2010 Oct;6(10):561-71. doi: 10.1038/nrrheum.2010.142. Epub 2010 Aug 31.
9
Challenges in the management of juvenile idiopathic arthritis with etanercept.使用依那西普治疗青少年特发性关节炎的管理挑战。
Biologics. 2009;3:127-39. Epub 2009 Jul 13.
10
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.治疗幼年特发性关节炎的生物疗法：来自成人和儿童治疗经验的启示。
Biologics. 2008 Jun;2(2):229-52. doi: 10.2147/btt.s2210.